Expand PEPG Menu
PEPG MENU

PEPG Latest Press Releases

-- May 21, 2026 --

PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting Clinical Data from the PGN-EDODM1 Program Business Wire 7:00 AM

-- May 12, 2026 --

PepGen Reports First Quarter 2026 Financial Results and Recent Corporate Highlights Business Wire 4:05 PM

-- April 30, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG PRNewswire 10:40 PM

-- April 28, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG Globe Newswire 5:19 PM

-- April 14, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG Globe Newswire 5:15 PM

-- April 7, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG Globe Newswire 4:57 PM

-- April 2, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG PRNewswire 10:01 AM

-- March 31, 2026 --

PepGen Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses Globe Newswire 10:33 AM

-- March 30, 2026 --

PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data Business Wire 4:05 PM

-- March 26, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG PRNewswire 10:00 AM

-- March 17, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG Globe Newswire 5:28 PM

-- March 12, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG PRNewswire 6:30 PM

-- March 5, 2026 --

PepGen Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses Globe Newswire 8:00 PM

-- March 4, 2026 --

PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights Business Wire 4:05 PM
PepGen Announces Regulatory Updates on FREEDOM2 Business Wire 4:03 PM

-- March 3, 2026 --

PepGen to Participate in the Leerink Global Healthcare Conference Business Wire 7:00 AM
Market Data Delayed 15 Minutes